SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.12.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.12.21 | Novartis Buy | Jefferies & Company Inc. | |
| 15.12.21 | Roche Neutral | UBS AG | |
| 14.12.21 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 13.12.21 | Roche Neutral | Credit Suisse Group | |
| 13.12.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 13.12.21 | Novartis Neutral | Credit Suisse Group | |
| 10.12.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.12.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 07.12.21 | Roche Buy | Jefferies & Company Inc. | |
| 07.12.21 | Novartis Buy | Jefferies & Company Inc. | |
| 06.12.21 | Novartis Sell | Deutsche Bank AG | |
| 03.12.21 | Novartis Neutral | UBS AG | |
| 03.12.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 02.12.21 | Roche Neutral | UBS AG | |
| 26.11.21 | Novartis Neutral | UBS AG | |
| 24.11.21 | Roche Neutral | UBS AG | |
| 24.11.21 | Roche Buy | Deutsche Bank AG | |
| 11.11.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.11.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.11.21 | Novartis Buy | Jefferies & Company Inc. | |
| 09.11.21 | Roche Neutral | UBS AG | |
| 05.11.21 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.11.21 | Novartis Neutral | UBS AG | |
| 04.11.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.11.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.11.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 04.11.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 04.11.21 | Roche Neutral | UBS AG | |
| 27.10.21 | Novartis Underweight | Barclays Capital | |
| 27.10.21 | Novartis Sell | Deutsche Bank AG | |
| 27.10.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.10.21 | Novartis Neutral | Credit Suisse Group | |
| 26.10.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.10.21 | Novartis Buy | UBS AG | |
| 26.10.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 26.10.21 | Novartis Sell | Deutsche Bank AG | |
| 26.10.21 | Roche Buy | Deutsche Bank AG | |
| 25.10.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.10.21 | Novartis Underweight | JP Morgan Chase & Co. |